Treatment of chronic kidney disease (CKD) subjects using lanthanum compounds
摘要
Disclosed is the use of a non-toxic lanthanum carbonate or lanthanum carbonate hydrate in the treatment of a subject susceptible to or suffering from soft tissue calcification associated with being at risk for chronic kidney disease (CKD) or stage one to stage four CKD.
申请公布号
NZ567519(A)
申请公布日期
2011.04.29
申请号
NZ20060567519
申请日期
2006.11.07
申请人
SHIRE INTERNATIONAL LICENSING B.V.
发明人
PRATT, RAYMOND DENNIS;WEBSTER, ISOBEL;DAMMENT, STEPHEN JP
